G protein‐coupled receptors: a count of 1001 conformations

@article{Vauquelin2005GPR,
  title={G protein‐coupled receptors: a count of 1001 conformations},
  author={Georges Vauquelin and Isabelle Van Liefde},
  journal={Fundamental \& Clinical Pharmacology},
  year={2005},
  volume={19}
}
G protein‐coupled receptors (GPCRs) were initially regarded to adopt an inactive and an active conformation and to activate a single type of G protein. Studies with recombinant cell systems have led to a more complex picture. First, GPCRs can activate distinct G protein species. Second, GPCR multistate models have been invoked to explain their complex behaviour in the presence of agonists, antagonists and other binding partners. The occurrence of intermediate receptor conformational states… Expand
2.20 – G Protein-Coupled Receptors
TLDR
Postgenomic evaluations indicate that there are over 100 GPCRs for which the endogenous ligand and the physiological and theraputic relevance are unknown, and target validation of this large number of potential therapeutic targets ensures that GPCR will continue to be one of the most important and expanding classes of drug discovery targets. Expand
Modulation of GPCR conformations by ligands, G-proteins, and arrestins.
TLDR
Over the past decade, researchers have studied the interaction of GPCRs, G-proteins, arrestins, and ligands in solubilized systems, where the concentration of each component can be defined. Expand
Molecular basis for high-affinity agonist binding in GPCRs
TLDR
Four active-state structures of the β1-adrenoceptor (β1AR) bound to conformation-specific nanobodies in the presence of agonists of varying efficacy are determined and elucidate how agonist binding is altered in the active conformation. Expand
Conformational changes in G‐protein‐coupled receptors—the quest for functionally selective conformations is open
TLDR
Recent progress in biophysical approaches that have led to the current understanding of conformational changes that occur during GPCR activation are summarized. Expand
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation
TLDR
Two crystal structures of the thermostabilized human adenosine A2A receptor bound to its endogenous agonistAdenosine and the synthetic agonist NECA are presented, indicating that the contraction of the ligand-binding pocket caused by the inward motion of helices 3, 5 and 7 may be a common feature in the activation of all GPCRs. Expand
Agonist-Selective Coupling of G Protein-Coupled Receptors
TLDR
Of particular importance is the emerging concept of functional selectivity, which explains the capacity of a ligand to selectively orientate the coupling of a receptor with a subset of G proteins, which is demonstrated for the vast majority of GPCRs. Expand
Simulations of Biased Agonists in the β2 Adrenergic Receptor with Accelerated Molecular Dynamics
TLDR
The dynamics of the β2 adrenergic receptor bound to the β-arrestin and G protein-biased agonists and the empty receptor are reported on to further characterize the receptor conformational changes caused by biased agonists. Expand
Structural Determinants for Ligand-Receptor Conformational Selection in a Peptide G Protein-coupled Receptor*
TLDR
The structural basis of selectivity of naturally occurring gonadotropin-releasing hormones (GnRHs) from different species in the single functional human GnRH receptor is explored and the highly variable amino acids in position 8 of the naturally occurring isoforms of GnRH play a discriminating role in selecting receptor conformational states. Expand
Modeling activated states of GPCRs: the rhodopsin template
TLDR
None of the normal modes calculated from the inactive structure has a dominant contribution along the path of conformational rearrangement from inactive to the active forms of RHO in the models, which may differentiate rhodopsin from other GPCRs, and the reasons for this difference are discussed. Expand
Utilization of Biased G Protein-Coupled Receptor Signaling towards Development of Safer and Personalized Therapeutics
TLDR
Recognizing specific downstream signaling pathways can be enriched while those that bring unwanted side effects can be prevented on a patient-specific basis will improve studies that centered on development of safer and personalized therapeutics, thus alleviating the burden on economy and public health. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 95 REFERENCES
G Protein-Coupled Receptor Allosterism and Complexing
TLDR
It is proposed that the study of allosteric phenomena will become of progressively greater import to the drug discovery process due to the advent of newer and more sensitive GPCR screening technologies. Expand
Functionally Different Agonists Induce Distinct Conformations in the G Protein Coupling Domain of the β2Adrenergic Receptor*
TLDR
Monitoring ligand-induced conformational changes in the G protein-coupling domain of the β2 adrenergic receptor provides new insight into the structural consequence of antagonist binding and the basis of agonism and partial agonism. Expand
G-protein-coupled receptor dimerization: modulation of receptor function.
TLDR
This review provides a brief overview of some of the techniques employed to describe GPCR dimers, and discusses their respective limitations, and examines the implications of dimerization/oligomerization on GPCRs function. Expand
G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction.
TLDR
A review of the recently described GPCR-interacting proteins and their individual functional roles, as understood, suggests that enhancement or disruption of target cell-specific events could serve as highly selective therapeutic opportunities. Expand
Lessons from constitutively active mutants of G protein-coupled receptors
TLDR
Describing how CAMs recapitulate the different structural modifications of the agonist-induced active conformation(s) of the wild-type receptor is a prerequisite for further use of CAMs as ligand-free models of active GPCRs in structural, cellular and physiological studies. Expand
Uncovering molecular mechanisms involved in activation of G protein-coupled receptors.
  • U. Gether
  • Biology, Medicine
  • Endocrine reviews
  • 2000
TLDR
The goal of the present review is to specifically address the physical changes linking agonist binding to receptor activation and subsequent transduction of the signal to the associated G protein on the cytoplasmic side of the membrane and to other putative signaling pathways. Expand
Biochemical and pharmacological control of the multiplicity of coupling at G-protein-coupled receptors.
  • E. Hermans
  • Biology, Medicine
  • Pharmacology & therapeutics
  • 2003
TLDR
This review aims at summarising the different studies that support the concept of multiplicity of G-protein coupling, and the physiological and pharmacological relevance of this coupling promiscuity will be discussed. Expand
The evolving role of lipid rafts and caveolae in G protein‐coupled receptor signaling: implications for molecular pharmacology
TLDR
The role of lipid rafts and a subpopulation of such rafts, caveolae, is focused on as a key spatial compartment enriched in components of GPCR signal transduction. Expand
Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling.
  • S. Ferguson
  • Biology, Medicine
  • Pharmacological reviews
  • 2001
TLDR
The focus of this review is the current and evolving understanding of the contribution of GRKs, beta-arrestins, and endocytosis to GPCR-specific patterns of desensitization and resensitized. Expand
Agonist induction and conformational selection during activation of a G-protein-coupled receptor.
TLDR
It is proposed that agonist induction should be considered as a general mechanism of GPCR activation. Expand
...
1
2
3
4
5
...